UNITED STATES SECURITIES AND EXCHANGE COMMISSION |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Exhibit Number | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File, formatted in Inline XBRL (included as Exhibit 101). |
Latch, Inc. | |||||||||||
Date: | May 5, 2022 | By: | /s/ Barry Schaeffer | ||||||||
Name: | Barry Schaeffer | ||||||||||
Title: | Interim Chief Financial Officer and Treasurer |
Three Months Ended March 31, | ||||||||||||||
(in thousands) | 2022 | 2021 | ||||||||||||
Net loss | $ | (44,231) | $ | (38,101) | ||||||||||
Depreciation and amortization | 1,506 | 653 | ||||||||||||
Interest expense, net(1) | 864 | 3,318 | ||||||||||||
Provision for income taxes | 17 | — | ||||||||||||
Change in fair value of derivative liabilities | — | 3,597 | ||||||||||||
Change in fair value of warrant liability | (6,267) | — | ||||||||||||
Change in fair value of trading securities | (1,000) | — | ||||||||||||
Transaction-related costs(2) | 538 | 2,148 | ||||||||||||
Litigation costs(3) | 40 | — | ||||||||||||
Stock-based compensation(4) | 11,718 | 14,493 | ||||||||||||
Adjusted EBITDA | $ | (36,815) | $ | (13,892) |
As of March 31, 2022 (unaudited) | As of December 31, 2021 | ||||||||||
Assets | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 90,959 | $ | 124,782 | |||||||
Available-for-sale securities - current | 172,993 | 158,973 | |||||||||
Accounts receivable, net | 28,967 | 25,642 | |||||||||
Inventories, net | 18,996 | 11,615 | |||||||||
Prepaid expenses and other current assets | 12,047 | 11,606 | |||||||||
Total current assets | 323,962 | 332,618 | |||||||||
Property and equipment, net | 2,755 | 2,039 | |||||||||
Available-for-sale securities - non-current | 71,058 | 102,878 | |||||||||
Internally developed software, net | 14,411 | 12,475 | |||||||||
Other non-current assets | 2,929 | 2,294 | |||||||||
Total assets | $ | 415,115 | $ | 452,304 | |||||||
Liabilities and Stockholders’ Equity (Deficit) | |||||||||||
Current liabilities | |||||||||||
Accounts payable | $ | 5,757 | $ | 6,229 | |||||||
Accrued expenses | 24,687 | 24,184 | |||||||||
Deferred revenue - current | 7,211 | 6,016 | |||||||||
Other current liabilities | 2,935 | 4,342 | |||||||||
Total current liabilities | 40,590 | 40,771 | |||||||||
Deferred revenue - non-current | 28,484 | 24,190 | |||||||||
Warrant liability | 3,520 | 9,787 | |||||||||
Other non current liabilities | 178 | — | |||||||||
Total liabilities | 72,772 | 74,748 | |||||||||
Commitments and contingencies (see Note 11) | |||||||||||
Stockholders’ equity (deficit) | |||||||||||
Common stock - $0.0001 par value, 1,000,000,000 shares authorized; 142,237,954 and 141,592,388 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively(1) | 32 | 25 | |||||||||
Additional paid-in capital | 718,305 | 706,713 | |||||||||
Accumulated other comprehensive loss | (2,292) | (676) | |||||||||
Accumulated deficit | (373,702) | (328,506) | |||||||||
Total stockholders’ equity (deficit) | 342,343 | 377,556 | |||||||||
Total liabilities and stockholders’ equity (deficit) | $ | 415,115 | $ | 452,304 |
Three Months Ended March 31, | ||||||||||||||
2022 | 2021 | |||||||||||||
Revenue: | ||||||||||||||
Hardware | $ | 9,055 | $ | 5,014 | ||||||||||
Software | 3,039 | 1,615 | ||||||||||||
Services | 1,561 | — | ||||||||||||
Total revenue | 13,655 | 6,629 | ||||||||||||
Cost of revenue(1)(2): | ||||||||||||||
Hardware | 10,992 | 6,028 | ||||||||||||
Software | 323 | 134 | ||||||||||||
Services | 1,718 | — | ||||||||||||
Total cost of revenue | 13,033 | 6,162 | ||||||||||||
Operating expenses: | ||||||||||||||
Research and development(2) | 18,257 | 9,615 | ||||||||||||
Sales and marketing(2) | 17,296 | 3,750 | ||||||||||||
General and administrative(2) | 14,178 | 17,696 | ||||||||||||
Depreciation and amortization | 1,506 | 653 | ||||||||||||
Total operating expenses | 51,237 | 31,714 | ||||||||||||
Loss from operations | (50,615) | (31,247) | ||||||||||||
Other income (expense) | ||||||||||||||
Change in fair value of warrant liability | 6,267 | — | ||||||||||||
Change in fair value of trading securities | 1,000 | — | ||||||||||||
Interest expense, net | (864) | (3,318) | ||||||||||||
Other expense | (2) | (3,536) | ||||||||||||
Total other income (expense), net | 6,401 | (6,854) | ||||||||||||
Loss before income taxes | (44,214) | (38,101) | ||||||||||||
Provision for income taxes | 17 | — | ||||||||||||
Net loss | $ | (44,231) | $ | (38,101) | ||||||||||
Other comprehensive loss | ||||||||||||||
Unrealized loss on available-for-sale securities | (1,618) | — | ||||||||||||
Foreign currency translation adjustment | 2 | (7) | ||||||||||||
Comprehensive loss | $ | (45,847) | $ | (38,108) | ||||||||||
Net loss per common share | ||||||||||||||
Basic and diluted net loss per common share | $ | (0.31) | $ | (3.65) | ||||||||||
Weighted average shares outstanding | ||||||||||||||
Basic and diluted | 141,970,190 | 10,438,778 | ||||||||||||
(1)Exclusive of depreciation and amortization shown in operating expenses below. | ||||||||||||||
(2)Stock-based compensation expense included in cost of revenue and operating expenses is as follows: | ||||||||||||||
Cost of revenue | $ | 272 | $ | 14 | ||||||||||
Research and development | 4,501 | 3,999 | ||||||||||||
Sales and marketing | 2,322 | 161 | ||||||||||||
General and administrative | 4,623 | 10,319 | ||||||||||||
Total stock-based compensation | $ | 11,718 | $ | 14,493 |
Three Months Ended March 31, | |||||||||||
2022 | 2021 | ||||||||||
Operating activities | |||||||||||
Net loss | $ | (44,231) | $ | (38,101) | |||||||
Adjustments to reconcile net loss to net cash used by operating activities | |||||||||||
Depreciation and amortization | 1,506 | 653 | |||||||||
Non-cash interest expense | 994 | 1,934 | |||||||||
Change in fair value of derivative liabilities | — | 3,597 | |||||||||
Change in fair value of warrant liability | (6,267) | — | |||||||||
Change in fair value of trading securities | (1,000) | — | |||||||||
Provision for excess and obsolete inventory | 665 | 9 | |||||||||
Allowance (reversal) for doubtful accounts | (50) | 171 | |||||||||
Stock-based compensation | 11,718 | 14,493 | |||||||||
Changes in assets and liabilities | |||||||||||
Accounts receivable | (4,241) | (1,108) | |||||||||
Inventories | (8,046) | 537 | |||||||||
Prepaid expenses and other current assets | 811 | (2,424) | |||||||||
Other non-current assets | (713) | (53) | |||||||||
Accounts payable | (471) | 1,732 | |||||||||
Accrued expenses | 199 | 1,331 | |||||||||
Other current liabilities | (344) | — | |||||||||
Other non-current liabilities | 178 | 620 | |||||||||
Deferred revenue | 5,489 | 2,279 | |||||||||
Net cash used in operating activities | (43,803) | (14,330) | |||||||||
Investing activities | |||||||||||
Purchase of available-for-sale securities | (24,367) | — | |||||||||
Proceeds from maturities of available-for-sale securities | 39,587 | — | |||||||||
Purchase of trading securities | (250) | — | |||||||||
Purchase of property and equipment | (736) | (290) | |||||||||
Development of internal software | (2,069) | (1,446) | |||||||||
Net cash provided by (used in) investing activities | 12,165 | (1,736) | |||||||||
Financing activities | |||||||||||
Proceeds from issuance of common stock | 180 | 2,035 | |||||||||
Payments for tax withholding on net settlement of equity awards | (1,293) | — | |||||||||
Proceeds from revolving credit facility | 1,345 | 53 | |||||||||
Repayment of revolving credit facility | (2,409) | — | |||||||||
Net cash (used in) provided by financing activities | (2,177) | 2,088 | |||||||||
Effect of exchange rate on cash | (8) | (9) | |||||||||
Net change in cash and cash equivalents | (33,823) | (13,987) | |||||||||
Cash and cash equivalents | |||||||||||
Beginning of period | 124,782 | 60,529 | |||||||||
End of period | $ | 90,959 | $ | 46,542 | |||||||
Supplemental disclosure of non-cash investing and financing activities | |||||||||||
Capitalization of stock-based compensation to internally developed software | $ | 1,019 | $ | 21 | |||||||
Capitalization of transaction costs | $ | — | $ | 3,412 | |||||||
Accrued issuance costs | $ | 25 | $ | — | |||||||
Accrued fixed assets | $ | 251 | $ | 67 | |||||||
Receivable from option exercises | $ | — | $ | 781 |
+2D3)\^':-%4+M(D&B7TM+2^/AX#/("K5JU.G+D"$Z'<:A=.*A=O!%[
M&_OVVV_CT9(2'!S,&@(WH%ME9>7_>)K035.!@8'X>K?;OGT[SB-7;FYNFS9M
M<$_,%QH:^LX+L;&QT='1[#^P800$!."_,QF[7&/OI7!2#$+MPD'MXHUV[=J%
MA\H%RY #F.0T=C)%S?,9>SW.N6HV2[9V=FX;:YSY\YA!#$?
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M.,5:)DV:A"EN<># 1R*ENG3IV.*6]B@77Q]??'UQ"VH78Q"[>))#H4
M2VEI*0;)ZM>O'VZ R\?'Q\7';QA+V79Y^O2IT!]=PL/#)9[#2%Q![<)![6)Y
M$DNY3)PX$5-
/D5C*9?7JU9CB=C=NW! MQ;BX.$PQF9KMPMY/X+:Y5JU:A1'$?$+MTJI5
MJT^]25!0$$Z!<]0NGB&WE,N3)T\PR!,2$A)P<%KR\O(PQ4QJMDMM;2UNFRLY
M.1DCB/D^%6F7#VGU,.>H73Q#8BF76;-F88J'G#QY$@>G9
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end
A$QI;IZ(!'F0Z28RI8METJ&U12+%DN['%CU(KBJ^W)
MB$!TC?AK'%W[(L_[75!>4%!JS>JE22S/H:J&3?"[6%,=@BW;M3'1-5VU%4^6
M90\DI?4 ,YKP2$PEV
M'8P9$\HTN\/ -_IAOH!R?7
M5@.X;LD%Q8]'51VA/AK3(1!^A#JOXMLROL&<9^JC8QRX(E9ED4C.+3$B)<)!
M* !I7DD\#J*FP9M"W[IZ95COEBW>QTG?_T?=SY='00Y*:CIB&DN0DI#
M%P8H1"'&6C/9^1YRXPB3%.(]6*,$)4Q@<-J6V:=$=JVP ^@9I[AV9Z9'56V)
M?D!!?>IQY%K:$E"]C+89]O^=A;=W\LI\?KJ\,N-Y;B@%9::0"@V)U@ARR 5C+D]]45-6E'Q
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MZ44U%XDMZQLI7#3E>J3=5DK8^DHY. 11IE[J6?N95 PT-03QZ1(U!$_,<\?
ME"98RPYK94^!'*>!A]53]=QCH$OC>D0L"WMBCJXRO*]23\I%VB#,_84V8:)H
ML"@<*.K=P4?8IFGE1 5I/4SD5+@O..Y9:.'^JRZ*J<)QPQ! 0AC79*8.8G!!Y)$H1-3SADOMTS>
M=^5\:_AY4=[1H9N,]6",%[G"A_IC77W-RP!39YB/&H4$&KOE8)SF.<&PV4PD
MT#*H3,KA0#^P_KQH]W'M)G(S&/*/5=.ZXC_YQ2(WC([[+/.&*,P>B-0! S%*
M2W@691"<1YPP# ?\GNWGA7MWMV["MGU@=[W,ZQK<0H=B7&>9P[8P3!.EDY@K
M.DE)9H.*0B5IA.B%]ZZUO0>ZL^NV+(ST6O?J'CD5'\^K
U7DG$P,*=;/?D6OVSN#JY7NW>8_N-UE$,LJ-
MQ[^X45C$%_,@= 5&THOWJ0E/H@WYY
M8
<[IE
VP[O&OTAF-CW.D:5K??[1I=:]3Y
M/P,6^08>%^]$\<+C?WTU<_V+*FET.G]YM?1
6!*^O-!K@'>]ER?IVL2"WG_?>J.W5@;C=K&SV_P^0T[V;)"@%/X
MMLQ+[NQ.8UX,$)VQ._Y_G?:?\[M76A3:JY^($>1"S?[\^]6,A7< SW$0Q\'L
ML@=[N^=A[-K,DW/0=.+K#-*]^?<,,=GZ=EG[\FPCF*VP&QL(AH?'PI(U BQ]
M9+$]U;[P>1#&D?:K&T:Q]L^$A; .0=N_NC[S;9@''HH2+XX.L+62(#H60/KF
M7\22'6X'(4-^=+.HAT.;'3<*P\MNVB740B:F8F(A"1(1F12)X".T>XK")V,JB(VXZC
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MCAO9213) 1^F"_0MW+MP:,O-@9N6'15/OI!VN(;NSP&X_1
M(ZG=
$32C'"T>![],IMVJ1.3CZ1VP,: ^BUJ GDUR%1
M&@.E.0PZTXS.Q3]1I;[V_82"=%>__0?H&5Z:^82+NBUX)6#'[[_;4[I#PF)G
MKG#[M0JIAK?O;](T0\Q($M?32*,-I7_(N^CJW60C#F=PX?&)2S$* U1V,C
M+
-X_!O8: 710)))T]ON;AD?A?@*CRX
MR*$<26$A3RC_/F6(<.S'\>\@22NUVH"#2>)1X3E1K#6%@!PN'2;%@&!86SB'
M;-XS3@M%<\%3O\#3VJ]B(,%,"VV4T3M4HB/C^QO\7JAN4I